RAP 0.00% 20.5¢ raptor resources limited

A new Beginning..., page-2373

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 3,464 Posts.
    lightbulb Created with Sketch. 956
    This post is the thoughts and opinions of author.

    Great post Red bar,

    Here we are now in February.

    Looking forward to posting a rocket launch on 1 st revenue beginning following CE Mark approval.
    It is very possible IMO, that CE Mark for Pediatric use will be approved this month.

    RAP press release November 14th 2018, "Resapp Clears Major Milestone for CE Mark and TGA approval with ISO 13485 Compliance"

    January 2nd 2019, ResApp Submits CE Mark Technical File for Acute Respiratory Disease Diagnostic Smartphone Application.

    Resapp poses no safety risk to user.
    Resapp has ISO 13485 compliance.
    Resapp is a diagnostic guide with strong clinical evidence of clinical and blind clinical trials testing on many thousands of patients.

    And as you point out Red bar, Resapp is 1000% better than what doctors current have for use during a telehealth consultation that is respiratory related.

    Sargent Dan bought me some shares in a cough company...
    Run RAP run.....

    Thank you Brian and the RAP team
    MB
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.